Tissue factor (TF), which is the main procoagulant, can contribute to tumor angiogenesis via mechanisms that are either dependent on or independent of blood clotting activation (e.g., TF-signaling elevating expression of molecules such as the main proangiogenic factor - vascular endothelial growth factor, VEGF). The gene discussed is TF; the disease is neoplasm.